U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. About FDA
  3. FDA Organization
  4. Office of Inspections and Investigations
  5. OII Inspectorates
  6. Office of Bioresearch Monitoring Inspectorate (OBMI)
  7. FDA Sponsor-Investigator Virtual Conference - 03/07/2023
  1. Office of Bioresearch Monitoring Inspectorate (OBMI)

Symposium | Virtual

Event Title
FDA Sponsor-Investigator Virtual Conference
March 7 - 9, 2023

Date:
March 7 - 9, 2023
Day1:
Tue, Mar 07 11:00 a.m. - 05:00 p.m. ET
Day2:
Wed, Mar 08 11:00 a.m. - 05:00 p.m. ET
Day3:
Thu, Mar 09 11:00 a.m. - 05:15 p.m. ET
Website:
https://www.socra.org/conferences-and-education/live-webinars/fda/program-information/

This virtual symposium is a distinct opportunity for Sponsor-Investigators and key research staff to receive targeted training directly from FDA, NIH, and research industry subject matter experts. It will provide insight into the unique dual-role of sponsor-investigators with in-depth coverage of the applicable FDA regulations, guidelines, and best practices. Attendees will take away tools for designing and managing quality research studies that will promote accurate and complete data submissions as well receive educational resources for improving overall compliance. The three (3) half-day schedule allows for less disruption to clinical practice and continuing education credits (CME/CNE/SOCRA CE) apply.

Enhanced understanding and application of both the sponsor and clinical investigator research responsibilities, by sponsor investigators, will strengthen the likelihood of: compliance with regulations, incorporation of quality aspects in research design and submissions, provide key principles for study start-up; proper study conduct and integrity of data, appropriate inclusion of  risk-based monitoring techniques and processes, along with ensuring the protection of human research subjects rights, safety and welfare. As a result, this provides FDA with the data on which to base its decisions regarding the acceptability of marketing applications. 

Duration: 3 half-days

CE Credit:  SOCRA designates this educational activity for a maximum of 16.25 Continuing Education Credits for SOCRA CE and Nurse CNE. SOCRA designates this live activity for a maximum of 16.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Audience: Sponsor-Investigators, IRB Administrators and Staff, Clinical Research Coordinators, Clinical Research Associates, and other professionals involved in FDA regulated research involving Sponsor-Investigators.
 

Back to Top